Meeting
2022 ASCO Annual Meeting
Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.
Presenter
Wungki Park, MD
Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4083)
DOI
10.1200/JCO.2022.40.16_suppl.4083
Abstract #
4083
Poster Bd #
71
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Gastrointestinal Cancers Symposium
Emerging Immunotherapy Biomarkers for Predicting Systemic Therapy in Hepatocellular Carcinoma
Speaker: Mark Yarchoan, MD
Videos & Slides
2021 ASCO Annual Meeting
Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.
Speaker: Rossin Erbe
Videos & Slides
2021 ASCO Annual Meeting
Multimodal profiling of biliary tract cancers to detect potentially actionable biomarkers and differences in immune signatures between subtypes.
Speaker: Kabir Mody, MD
Videos & Slides
2017 ASCO Annual Meeting
Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.
Speaker: Niki Karachaliou, M.D., PhD